Literature DB >> 24290774

Spectrum of imaging findings on MDCT enterography in patients with small bowel tuberculosis.

N Kalra1, P Agrawal2, V Mittal2, R Kochhar3, V Gupta4, R Nada5, R Singh4, N Khandelwal2.   

Abstract

Abdominal tuberculosis (TB) is the sixth most common extrapulmonary site of involvement. The sites of involvement in abdominal tuberculosis, in descending order of frequency, are lymph nodes, genitourinary tract, peritoneal cavity, and gastrointestinal tract. The radiological armamentarium for evaluating tuberculosis of the small bowel (SBTB) includes barium studies (small bowel follow-through, SBFT), CT (multidetector CT, CT enterography, and CT enteroclysis), ultrasound (sonoenteroclysis), and magnetic resonance imaging (MRI; enterography and enteroclysis). In this review, we illustrate the abnormalities at MDCT enterography in 20 consecutive patients with SB TB and also describe extraluminal findings in these patients. MDCT enterography allows non-invasive good-quality assessment of well-distended bowel loops and the adjacent soft tissues. It displays the thickness and enhancement of the entire bowel wall in all three planes and allows examination of all bowel loops, especially the ileal loops, which are mostly superimposed. The terminal ileum and ileocaecal junction are the most common sites of small bowel involvement in intestinal TB. The most common abnormality is short-segment strictures with symmetrical concentric mural thickening and homogeneous mural enhancement. Other findings include lymphadenopathy, ascites, enteroliths, peritoneal thickening, and enhancement. In conclusion, MDCT enterography is a comprehensive technique for the evaluation of SB TB.
Copyright © 2013 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24290774     DOI: 10.1016/j.crad.2013.10.009

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  8 in total

Review 1.  Differential diagnosis of Crohn's disease versus ileal tuberculosis.

Authors:  Ajit Sood; Vandana Midha; Arshdeep Singh
Journal:  Curr Gastroenterol Rep       Date:  2014-11

Review 2.  Hepatic and Intra-abdominal Tuberculosis: 2016 Update.

Authors:  Richard P T Evans; Moustafa Mabrouk Mourad; Lee Dvorkin; Simon R Bramhall
Journal:  Curr Infect Dis Rep       Date:  2016-12       Impact factor: 3.725

3.  Evaluation of intestinal tuberculosis by multi-slice computed tomography enterography.

Authors:  Jing Zhao; Min-Yi Cui; Tao Chan; Ren Mao; Yanji Luo; Indira Barua; Minhu Chen; Zi-Ping Li; Shi-Ting Feng
Journal:  BMC Infect Dis       Date:  2015-12-22       Impact factor: 3.090

4.  Intestinal tuberculosis versus crohn's disease: Clinical and radiological recommendations.

Authors:  Raju Sharma; Kumble S Madhusudhan; Vineet Ahuja
Journal:  Indian J Radiol Imaging       Date:  2016 Apr-Jun

Review 5.  Kaleidoscopic View of Bowel Tuberculosis on Multi- Detector Computed Tomography (CT) Enterography - A Novel Technique Unfolding an Archaic Disease.

Authors:  Shuchi Bhatt; Satarupa Roy; Naveen Bhardwaj; Anupama Tandon; Vikas Kumar Singh; Bhupender Kumar Jain; Samrat Mandal
Journal:  Pol J Radiol       Date:  2017-12-15

6.  Systematic reporting of computed tomography enterography/enteroclysis as an aid to reduce diagnostic dilemma when differentiating between intestinal tuberculosis and Crohn's disease: A prospective study at a tertiary care hospital.

Authors:  Amrin Israrahmed; Rajanikant R Yadav; Geeta Yadav; Rajesh V Helavar; Praveer Rai; Manoj Kumar Jain; Archna Gupta
Journal:  JGH Open       Date:  2020-12-14

7.  Treatment of intestinal tuberculosis with small bowel perforation: a case report.

Authors:  Daniel Sasse; Christoph D Spinner; Kathrin Rothe; Jochen Schneider; Jochen Gaa; Silvia Würstle
Journal:  J Med Case Rep       Date:  2021-03-31

8.  Distinguishing between Crohn's disease, tuberculosis, and lymphoma: still in murky waters.

Authors:  Majid A Almadi
Journal:  Saudi J Gastroenterol       Date:  2014 Jul-Aug       Impact factor: 2.485

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.